A 28-year-old man has revealed a harrowing nine-month struggle with a popular hair loss drug, describing the mostly sexual ...

Daily Mail journalists select and curate the products that feature on our site. If you make a purchase via links on this page we will earn commission - learn more Hair loss is, for many, an ...

Hims & Hers Health (HIMS) stock declined about 2% yesterday. The fall came after the U.S. Food and Drug Administration (FDA) issued a warning about topical finasteride, a hair-loss treatment sold ...

The FDA issued a public alert on Tuesday concerning generic versions of a widely-used hair loss drug that is frequently distributed by popular telehealth brands like Hims and Keeps. The agency ...

The platform addresses issues such as hair loss, sexual health, weight management, skincare and mental health. Hims provides access to personalized treatment plans through online consultations ...

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity. Consumers will now be able to access ...

Founded in 2017, Hims is a telemedicine platform that offers medical services and treatments related to sexual health, hair loss, anxiety, skin care, and more. Hims connects its customers with ...